MedTrace Logo

Smoking Cessation Intervention for Diabetic Patients

NCT01501877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-12

No results posted yet for this study

Summary

This study is designed to develop and test a smoking cessation intervention for smokers with Type 2 diabetes.

Conditions

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy

The intervention is based on Acceptance and Commitment Therapy and will be tailored to smokers with Type 2 diabetes.

BEHAVIORAL

Standard smoking cessation intervention

Standard smoking cessation intervention based on clinical practice guidelines.

Sponsors & Collaborators

  • Rhode Island Hospital

    lead OTHER

Principal Investigators

  • Susan E. Ramsey, Ph.D. · Rhode Island Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501877 on ClinicalTrials.gov